Abbvie Inc (NYSE:ABBV)
| 147.40 Delayed Data As of 4:00pm ET |  -0.39 / -0.26%Today’s Change | 132.83 Today|||52-Week Range 175.91 | -8.79% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 147.79 |
| Today’s open | 148.34 |
| Day’s range | 147.12 - 148.69 |
| Volume | 4,576,999 |
| Average volume (3 months) | 5,657,170 |
| Market cap | $264.5B |
Data as of 4:00pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +137.07% |
| Earnings growth (this year) | +8.65% |
| Earnings growth (next 5 years) | +0.60% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 19.7 |
| Price/Sales | 4.28 |
| Price/Book | 17.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.40 | -0.90% |
| MRKMerck | -1.70 | -1.57% |
| NVONovo Nordisk | -1.38 | -0.99% |
| AZNAstraZeneca | -0.65 | -0.98% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | February 9, 2023 |
| EPS forecast (this quarter) | $3.53 |
| Annual revenue (last year) | $56.2B |
| Annual profit (last year) | $11.5B |
| Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
